Literature DB >> 12598988

Upper limb vein anatomy before hemodialysis fistula creation: cross-sectional anatomy using MR venography.

Jean-Pierre Laissy1, Pedro Fernandez, Pascale Karila-Cohen, Vincent Delmas, Emmanuel Dupuy, Sylvie Chillon, Françoise Mignon, Elisabeth Schouman-Claeys.   

Abstract

Preoperative imaging is indicated to discriminate patent, adequate superficial veins of the upper limbs undetectable by clinical inspection that could be anastomosed for the creation of a durable and functional hemodialysis fistula. The aim of this pictorial review is to provide a venous anatomic map of the upper limbs using MR venography (MRV) which could help surgeons before creation of hemodialysis access fistulas (AVF). At the level of the forearm, the antebrachial cephalic vein is the most commonly identified as patent. At the level of the elbow and distal arm, the cephalic vein is patent in 80% of normal subjects, and less often patent (23-26%) than basilic vein (33-38%) in patients. Overall, reading transaxial MR views can help for assessing upper limb vein anatomy before creation of a hemodialysis access fistula.

Entities:  

Mesh:

Year:  2002        PMID: 12598988     DOI: 10.1007/s00330-002-1402-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  MR venography needs to know where it stands for vascular mapping prior to fistula creation.

Authors:  Ismail Mihmanli; Fatih Kantarci
Journal:  Eur Radiol       Date:  2003-08-20       Impact factor: 5.315

Review 2.  Diagnosis and management of deep vein thrombosis of the upper extremity: a review.

Authors:  Henk J Baarslag; Maria M W Koopman; Jim A Reekers; Edwin J R van Beek
Journal:  Eur Radiol       Date:  2004-02-26       Impact factor: 5.315

3.  Magnetic resonance angiographic assessment of upper extremity vessels prior to vascular access surgery: feasibility and accuracy.

Authors:  Nils R Planken; Jan H Tordoir; Lucien E Duijm; Harrie C van den Bosch; Frank M van der Sande; Jeroen P Kooman; Michiel W de Haan; Tim Leiner
Journal:  Eur Radiol       Date:  2007-07-24       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.